Evidence map›Paper›PMID 33411955›Full record

ArticleInternational journal of cancer2021

Colorectal cancer risk variants rs10161980 and rs7495132 are associated with cancer survival outcome by a recessive mode of inheritance.

Yazhou He, Maria Timofeeva, Xiaomeng Zhang, Wei Xu, Xue Li, Farhat V N Din, Victoria Svinti, Susan M Farrington, Harry Campbell, Malcolm G Dunlop and 1 more

Abstract read
In one paragraph

Article in International journal of cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. International journal of general medicine · 2022
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yazhou HeDepartment of Oncology, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, People's Republic of China.ORCID 0000-0003-2358-0143
Maria TimofeevaColon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Medical Research Council Institute of Genetics & Molecular Medicine, Western General Hospital, The University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-2503-4253
Xiaomeng ZhangCentre for Global Health, Usher Institute, The University of Edinburgh, Edinburgh, UK.
Wei XuCentre for Global Health, Usher Institute, The University of Edinburgh, Edinburgh, UK.
Xue LiCentre for Global Health, Usher Institute, The University of Edinburgh, Edinburgh, UK.ORCID 0000-0001-6880-2577
Farhat V N DinCancer Research UK Edinburgh Centre, Medical Research Council Institute of Genetics & Molecular Medicine, Western General Hospital, The University of Edinburgh, Edinburgh, UK.
Victoria SvintiColon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Medical Research Council Institute of Genetics & Molecular Medicine, Western General Hospital, The University of Edinburgh, Edinburgh, UK.
Susan M FarringtonCancer Research UK Edinburgh Centre, Medical Research Council Institute of Genetics & Molecular Medicine, Western General Hospital, The University of Edinburgh, Edinburgh, UK.
Harry CampbellCentre for Global Health, Usher Institute, The University of Edinburgh, Edinburgh, UK.
Malcolm G DunlopCancer Research UK Edinburgh Centre, Medical Research Council Institute of Genetics & Molecular Medicine, Western General Hospital, The University of Edinburgh, Edinburgh, UK.
Evropi TheodoratouCancer Research UK Edinburgh Centre, Medical Research Council Institute of Genetics & Molecular Medicine, Western General Hospital, The University of Edinburgh, Edinburgh, UK.

Funding

Cancer Research UK 12076Cancer Research UK 18927Cancer Research UK 22804Cancer Research UK C31250/A22804Cancer Research UK C348/A18927Medical Research Council MC_PC_17228Medical Research Council MC_PC_U127527198Medical Research Council MC_QA137853Medical Research Council MC_U127527198Medical Research Council MC_UU_00007/1Medical Research Council MR/K018647/1Wellcome Trust
6 · The paper itself

Abstract

Previous studies using additive genetic models failed to identify robust evidence of associations between colorectal cancer (CRC) risk variants and survival outcomes. However, additive models can be prone to false negative detection if the underlying inheritance mode is recessive. Here, we tested all currently known CRC-risk variants (n = 129) in a discovery analysis of 5675 patients from a Scottish cohort. Significant associations were then validated in 2474 CRC cases from UK Biobank. We found that the TT genotype of the intron variant rs7495132 in the CRTC3 gene was associated with clinically relevant poorer CRC-specific survival in both the discovery (hazard ratio [HR] = 1.97, 95% confidence interval [CI] = 1.41-2.74, P = 6.1 × 10

Indexed as

Polymorphism, Single NucleotideAgedBiological Specimen BanksColorectal NeoplasmsFemaleGenetic Association StudiesGenetic Predisposition to DiseaseHumansMaleMiddle AgedRNA, Long NoncodingScotlandSurvival AnalysisRNA, Long Noncodingcolorectal cancergermline genetic variantsrecessive modelsurvival outcomes

Identifiers

PMID33411955
PMCPMC8614120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.